Trump’s $529 Billion Drug Price Gamble: Inside the Most Favored Nation Plan to Reset US Pharma Costs
The United States is entering a pivotal phase in pharmaceutical policy reform, anchored in a sweeping experiment known as the Most Favored Nation drug pricing model. The initiative is being positioned as

Follow